Please login to the form below

Not currently logged in
Email:
Password:

malignant glioma

This page shows the latest malignant glioma news and features for those working in and with pharma, biotech and healthcare.

BMS signs $1.74bn deal to boost immuno-oncology portfolio

BMS signs $1.74bn deal to boost immuno-oncology portfolio

malignant cells. ... and malignant glioma.

Latest news

  • BMS' Opdivo set for early access in UK BMS' Opdivo set for early access in UK

    Until now, the only PIM granted under the scheme was for Northwest Biotherapeutics' cell-based therapy DCVax-L for a form of brain cancer known as malignant glioma.

  • FDA grants orphan status to Activartis’ brain cancer immunotherapy FDA grants orphan status to Activartis’ brain cancer immunotherapy

    FDA grants orphan status to Activartis’ brain cancer immunotherapy. Regulator says AV0113 has potential in rare cancer malignant glioma. ... The Austria-based biotech said the US regulator gave the designation for AV0113's use in the treatment

  • Roche's Avastin gains Japanese approval for brain cancer Roche's Avastin gains Japanese approval for brain cancer

    The Japanese drug regulator has approved Roche's Avastin (bevacizumab) for malignant glioma and newly diagnosed glioblastoma (GBM), in combination with radiotherapy and temozolomide chemotherapy. ... The estimated number of newly diagnosed malignant

  • Ark files documentation on Cerepro

    gene-based therapy for the treatment of operable malignant glioma (brain cancer). ... Malignant glioma is a fatal form of brain tumour that is usually confined to the brain.

  • Close but no cigar

    Both are being reviewed by the EMEA for the treatment of head and neck cancer and glioma, respectively. ... glioma, compared with patients receiving standard care alone (either surgery and radiotherapy or surgery and radiotherapy plus temozolomide).

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics